Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype

Individualizing adjuvant chemotherapy is important in patients with advanced colorectal cancers (CRCs), and the ability to identify molecular subtypes predictive of good prognosis for stage III CRCs after adjuvant chemotherapy could be highly beneficial. We performed microarray-based gene expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Yujin, Park, Minhee, Jang, Mi, Yun, Seongju, Kim, Won Kyu, Kim, Sora, Paik, Soonmyung, Lee, Hyun Jung, Hong, Sungpil, Kim, Tae Il, Min, Byungsoh, Kim, Hoguen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503619/
https://www.ncbi.nlm.nih.gov/pubmed/28455965
http://dx.doi.org/10.18632/oncotarget.17023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503619/
https://www.ncbi.nlm.nih.gov/pubmed/28455965
http://dx.doi.org/10.18632/oncotarget.17023

Ejemplares similares